(59 days)
Not Found
No
The document describes a control material for a urinalysis analyzer, not the analyzer itself. The description focuses on the composition and stability of the control, with no mention of AI or ML technology.
No
The device is a cellular urine control used for evaluating the accuracy and precision of automated procedures that measure urinary sediment parameters, not for treating any condition.
No.
This device is a control material used for evaluating the accuracy and precision of automated procedures that measure urinary sediment parameters, not a diagnostic device itself.
No
The device description clearly states it is a "urinalysis control which contains stabilized human red and white blood cells and other inert particles in a preservative medium," indicating it is a physical substance, not software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that it is a "cellular urine control for evaluating the accuracy and precision of automated procedures that measure urinary sediment parameters." This indicates it is used in vitro (outside the body) to assess the performance of a diagnostic test (measuring urinary sediment parameters).
- Device Description: It is described as a "urinalysis control" containing stabilized biological components (red and white blood cells) in a preservative medium. Controls are a fundamental part of IVD testing to ensure the reliability of the analytical process.
- Function: Its purpose is to evaluate the accuracy and precision of an automated analyzer (IRIS iQ® 200 analyzer) used for urinalysis, which is a common IVD procedure.
The definition of an IVD generally includes reagents, calibrators, control materials, kits, instruments, apparatus, equipment, or systems intended for use in the in vitro examination of specimens derived from the human body for the purpose of providing information for diagnostic, monitoring, or compatibility purposes. This device fits the description of a control material used in an in vitro examination.
N/A
Intended Use / Indications for Use
UA-Cellular for IQ is an assayed cellular urine control for evaluating the accuracy and precision of automated procedures that measure urinary sediment parameters.
Product codes
JPK
Device Description
UA-Cellular for IQ is a urinalysis control which contains stabilized human red and white blood cells and other inert particles in a preservative medium. UA-Cellular for IQ is a urine control for the IRIS iQ® 200 analyzer. The product is packaged in plastic bottles containing 120ml. The closures are polypropylene screw caps with polyethylene liners. There are two different levels: level 1 and level 2. The bottles will be packaged in a box with the package insert / assay sheet. The product must be stored at 2 - 10° C.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Three types of studies were conducted to establish performance of UA-Cellular for IQ. The three tests conducted were Run-to-Run Reproducibility, Open Vial Stability and Closed Vial Stability. All testing showed that UA-Cellular for IQ is consistently reproducible, substantially equivalent to the predicate product and stable for the shelf life claimed.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 864.8625 Hematology quality control mixture.
(a)
Identification. A hematology quality control mixture is a device used to ascertain the accuracy and precision of manual, semiautomated, and automated determinations of cell parameters such as white cell count (WBC), red cell count (RBC), platelet count (PLT), hemoglobin, hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC).(b)
Classification. Class II (special controls). Except when intended for use in blood components, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.
0
MAR 2 7 2009
510(k) Summary of Safety and Effectiveness
| 510(k) Submitter: | Streck
7002 South 109th Street
Omaha, NE 68128 |
|------------------------------------------------------------------------|--------------------------------------------------------------------------------------------|
| Official Correspondent: | Carol Thompson, Quality Assurance Manager
(402)-537-5213 |
| Date Prepared: | March 25, 2009 |
| Name of Device:
Trade Name:
Common Name:
Classification Name: | UA-Cellular™ for IQ
Urinalysis Control
Hematology quality control mixture (864.8625) |
| Predicate Device: | Cell-Chex Auto (K053362) Manufactured by Streck |
Description:
UA-Cellular for IQ is a urinalysis control which contains stabilized human red and white blood cells and other inert particles in a preservative medium. UA-Cellular for IQ is a urine control for the IRIS iQ® 200 analyzer. The product is packaged in plastic bottles containing 120ml. The closures are polypropylene screw caps with polyethylene liners. There are two different levels: level 1 and level 2. The bottles will be packaged in a box with the package insert / assay sheet. The product must be stored at 2 - 10° C.
Intended Use:
UA-Cellular for IQ is an assayed cellular urine control for evaluating the accuracy and precision of automated procedures that measure urinary sediment parameters.
| | Cell-Chex Auto (Predicate
Product) | UA-Cellular for IQ |
|---------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use
Statement | Cell-Chex Auto is an assayed whole
blood control for evaluating the
accuracy and precision of
hematology instruments that
measure blood cell counts in patient
body fluid samples. | UA-Cellular for IQ is an assayed
cellular urine control for evaluating
the accuracy and precision of
automated procedures that
measure urinary sediment
parameters. |
| Open Vial Stability | 30 days | Same |
| Closed Vial
Stability | 75 days | 60 days |
| Reagents | Stabilized human red and white
cells | Same stabilized human red and
white cells combined with non-
squamous simulated epithelial and
crystal components |
| Storage
Conditions | 2 - 10°C | Same |
Comparison to Predicate Device:
1
Discussion of Tests and Test Results:
Three types of studies were conducted to establish performance of UA-Cellular for IQ. The three tests conducted were Run-to-Run Reproducibility, Open Vial Stability and Closed Vial Stability. All testing showed that UA-Cellular for IQ is consistently reproducible, substantially equivalent to the predicate product and stable for the shelf life claimed.
Conclusions Drawn From Tests:
UA-Cellular for IQ is an assayed cellular urine control for evaluating the accuracy and precision of automated procedures that measure urinary sediment parameters. It meets the claim of a 60 day closed vial, and a 30 day open vial stability and consistent run-to-run performance. Reproducibility studies and Closed Vial stability results confirm lot-to-lot consistency in the manufacture of UA-Cellular for IQ. Customers can be assured of a reliable quality control material that meets their expectations.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or other bird with outstretched wings.
Public Health Service
MAR 2 7 2009
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
Streck c/o Kerrie Oetter Quality Assurance Coordinator 7002 South 109th St. Omaha, Nebraska 68128
Re: K090201
Trade/Device Name: UA-Cellular™ for IQ Regulation Number: 21 CFR 864.8625 Regulation Name: Hematology Quality Control Mixture Regulatory Class: II Product Code: JPK Dated: January 26, 2009 Received: January 27, 2009
Dear Ms. Oetter:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. However, you are responsible to determine that the medical devices you use as components in the [kit/tray] have either been determined as substantially equivalent under the premarket notification process (Section 510(k) of the act), or were legally on the market prior to May 28, 1976, the enactment date of the Medical Device Amendments. Please note: If you purchase your device components in bulk (i.e., unfinished) and further process (e.g., sterilize) you must submit a new 510(k) before including these components in your kit/tray. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, and labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2- Ms. Oetter
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on the labeling regulation, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at 240- 276-0450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For question regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR), please contact the Division of Surveillance Systems at 240-276-3464. You many obtain other general information on your responsibilities under the Act from the Division of Small Manufactuers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
for Maria M. Chan, Ph.D.
Director
Division of Immunology and Hematology Devices Office of In Vitro Diagnostic Device Evaluation and Safety
Center for Devices and Radiological Health
Enclosure
4
Indication for Use
510(k) Number (if known):
Device Name: UA-Cellular™ for IQ
Indication For Use:
UA-Cellular for IQ is an assayed cellular urine control for evaluating the accuracy and precision of automated procedures that measure urinary sediment parameters.
Prescription Use X (21 CFR Part 801 Subpart D) And/Or
Over the Counter Use (21 CFR Part 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE; CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)
Josephine Bautista
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) K09020/
Page 1 of 1
్లో ఒ